Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 23, Issue 9, Pages 2409-2414
Publisher
Oxford University Press (OUP)
Online
2012-02-22
DOI
10.1093/annonc/mdr626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impressive Response With Imatinib in a Heavily Pretreated Patient With Metastatic c-KIT Mutated Thymic Carcinoma
- (2011) Sebastiano Buti et al. JOURNAL OF CLINICAL ONCOLOGY
- Sunitinib in metastatic thymic carcinomas: Laboratory findings and initial clinical experience
- (2010) P Ströbel et al. BRITISH JOURNAL OF CANCER
- Good Clinical Response to Imatinib Mesylate in Atypical Thymic Carcinoid With KIT Overexpression
- (2010) Satoshi Hamada et al. JOURNAL OF CLINICAL ONCOLOGY
- The GIST paradigm: lessons for other kinase-driven cancers
- (2010) Cristina R Antonescu JOURNAL OF PATHOLOGY
- Thymic Tumors: Relevant Molecular Data in the Clinic
- (2010) Nicolas Girard Journal of Thoracic Oncology
- Targeted Therapy for Advanced Thymic Tumors
- (2010) Arun Rajan et al. Journal of Thoracic Oncology
- Expression and Mutational Status of c-kit in Thymic Epithelial Tumors
- (2010) Iacopo Petrini et al. Journal of Thoracic Oncology
- Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation
- (2010) Umut Dişel et al. LUNG CANCER
- Thymic Carcinoma: Is it a Separate Entity? From Molecular to Clinical Evidence
- (2010) Alexander Marx et al. Thoracic Surgery Clinics
- Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas
- (2009) N. Girard et al. CLINICAL CANCER RESEARCH
- Long Lasting Response to the Multikinase Inhibitor Bay 43-9006 (Sorafenib) in a Heavily Pretreated Metastatic Thymic Carcinoma
- (2009) Giancarlo Bisagni et al. Journal of Thoracic Oncology
- Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas
- (2009) Giuseppe Giaccone et al. Journal of Thoracic Oncology
- Molecular Pathology of Thymic Epithelial Neoplasms
- (2008) Elisabetta Kuhn et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Absence of gene mutations in KIT-positive thymic epithelial tumors
- (2008) Masanori Tsuchida et al. LUNG CANCER
- A review of thymic tumours
- (2008) R. Srirajaskanthan et al. LUNG CANCER
- Mutational status of EGFR and KIT in thymoma and thymic carcinoma
- (2008) Kiyotaka Yoh et al. LUNG CANCER
- Response to sorafenib in cisplatin-resistant thymic carcinoma: a case report
- (2008) Xiao-feng Li et al. MEDICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More